TPV 250 (Aptivus 250 mg)

Generic Name: tipranavir

Pill imprint TPV 250 has been identified as Aptivus 250 mg.

Aptivus is used in the treatment of hiv infection and belongs to the drug class protease inhibitors. Risk cannot be ruled out during pregnancy. Aptivus 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Aptivus

Generic Name:

tipranavir

Imprint:

TPV 250

Strength:

250 mg

Color:

Pink

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Protease inhibitors

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Boehringer Ingelheim Pharmaceuticals, Inc.

National Drug Code (NDC):

00597-0003

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
54569-5719	A-S Medication Solutions, LLC (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.